FDA Open to Suggestions for Overcoming Drug Development Obstacles | GenomeWeb

NEW YORK, April 22 (GenomeWeb News) - The US Food and Drug Administration has established a public docket to obtain information on the major hurdles in drug, device, and biologic development, and to solicit proposed solutions.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.